NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX)

Historical Holders from Q2 2016 to Q4 2025

Type / Class: Equity / Common Stock, Par Value $0.01 per share
Symbol: NVAX on Nasdaq
Shares outstanding: 162,190,120
Price per share: $6.72
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 103,177,862
Total reported value: $894,342,655
% of total 13F portfolios: 0%
Share change: +1,271,274
Value change: +$22,913,349
Number of holders: 241
Price from insider filings: $6.72

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SHAH CAPITAL MANAGEMENT	8.3%	+14%	$116,713,633	+$14,305,500	13,461,780	+14%	Himanshu H. Shah	10 Nov 2025
BlackRock, Inc.	8.4%		$90,252,258		13,450,411		BlackRock, Inc.	31 Dec 2024

As of 30 Sep 2025, NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 241 institutional shareholders filing 13F forms. They hold 103,177,862 shares. of 162,190,120 outstanding shares (64%) .

Top 25 institutional shareholders own 56% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	9.4%	15,194,563	-1.5%	0%	$131,736,862
BlackRock, Inc.	7.9%	12,773,053	+0.23%	0%	$110,742,371
SHAH CAPITAL MANAGEMENT	7.3%	11,811,780	+2.6%	18%	$102,408,133
STATE STREET CORP	4.4%	7,196,719	+5.5%	0%	$62,395,554
Sanofi	4.2%	6,880,481	0%	23%	$59,653,770
D. E. Shaw & Co., Inc.	2.6%	4,274,079	+8.5%	0.03%	$37,056,265
COATUE MANAGEMENT LLC	2.4%	3,836,986	0%	0.08%	$33,266,669
GEODE CAPITAL MANAGEMENT, LLC	2.3%	3,792,064	+0.63%	0%	$32,882,382
UBS Group AG	2.2%	3,516,203	+56%	0.01%	$30,485,480
BANK OF AMERICA CORP /DE/	1.9%	3,101,074	-1.1%	0%	$26,886,311
MILLENNIUM MANAGEMENT LLC	1.3%	2,127,279	+5.2%	0.01%	$18,443,509
NORTHERN TRUST CORP	0.94%	1,529,117	+15%	0%	$13,257,445
Allianz Asset Management GmbH	0.87%	1,409,734	+163%	0.02%	$12,222,394
TSP Capital Management Group, LLC	0.86%	1,399,065		3.2%	$12,129,894
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.82%	1,331,286	+1%	0%	$11,542,250
CITADEL ADVISORS LLC	0.79%	1,285,872	+55%	0.01%	$11,148,510
HRT FINANCIAL LP	0.77%	1,245,708	+102%	0.04%	$10,800,000
RENAISSANCE TECHNOLOGIES LLC	0.74%	1,196,750	+79%	0.01%	$10,375,823
ROYAL BANK OF CANADA	0.71%	1,144,118	+6.2%	0%	$9,918,000
MORGAN STANLEY	0.66%	1,076,444	-13%	0%	$9,332,786
SG Americas Securities, LLC	0.57%	918,683	+1.8%	0.03%	$7,965,000
GOLDMAN SACHS GROUP INC	0.49%	789,276	-2.2%	0%	$6,843,023
FARALLON CAPITAL MANAGEMENT LLC	0.48%	780,000	+4775%	0.04%	$6,762,600
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.45%	729,956	-22%	0.01%	$6,328,718
TWO SIGMA INVESTMENTS, LP	0.43%	702,000	+30%	0.01%	$6,086,340

Institutional Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	994,240	$6,680,965	+$375,757			$6.72	7
2025 Q3	103,177,862	$894,342,655	+$22,913,349	$77,919,891	$47,400,757	$8.67	241
2025 Q2	101,926,921	$642,596,235	+$26,723,556	$50,386,140	$37,008,720	$6.30	245
2025 Q1	98,489,289	$631,402,819	-$31,743,582	$42,169,164	$36,156,362	$6.41	239
2024 Q4	102,621,538	$825,131,401	-$12,498,087	$70,262,461	$42,741,765	$8.04	226
2024 Q3	93,728,334	$1,185,512,029	+$128,224,618	$118,581,063	$86,834,457	$12.63	225
2024 Q2	83,464,759	$1,059,918,322	+$101,312,152	$113,761,046	$67,634,784	$12.66	220
2024 Q1	75,527,682	$361,018,382	-$3,812,627	$30,993,998	$22,890,464	$4.78	189
2023 Q4	76,725,820	$368,301,338	+$60,349,311	$41,074,559	$40,542,720	$4.80	191
2023 Q3	61,747,470	$447,039,158	+$35,454,803	$69,722,648	$58,419,560	$7.24	218
2023 Q2	56,705,546	$421,251,592	-$21,077,107	$68,526,174	$42,770,052	$7.43	202
2023 Q1	60,022,038	$415,977,902	+$24,129,521	$67,907,824	$55,463,057	$6.93	208
2022 Q4	52,556,924	$540,013,841	+$137,141,602	$79,721,280	$75,558,172	$10.28	236
2022 Q3	36,188,483	$658,924,088	-$41,541,447	$86,946,520	$72,906,500	$18.20	214
2022 Q2	33,896,260	$1,743,667,465	-$19,484,059	$292,822,891	$220,951,281	$51.43	288
2022 Q1	33,373,084	$2,458,716,103	-$55,536,369	$631,415,465	$333,210,145	$73.65	346
2021 Q4	33,397,602	$4,783,479,130	-$707,719,453	$1,750,299,443	$888,644,000	$143.07	399
2021 Q3	37,367,414	$7,745,430,573	-$523,926,966	$1,271,158,539	$1,000,894,996	$207.31	412
2021 Q2	39,714,489	$8,429,599,286	-$519,994,166	$948,745,562	$921,324,993	$212.31	394
2021 Q1	42,385,643	$7,684,705,204	+$831,207,087	$638,153,790	$740,746,392	$181.31	369
2020 Q4	38,737,001	$4,320,546,392	+$723,829,689	$542,190,720	$362,225,000	$111.51	327
2020 Q3	32,274,360	$3,495,919,877	+$140,194,009	$456,307,000	$391,025,000	$108.35	299
2020 Q2	28,744,068	$2,396,362,967	+$1,445,662,354	$221,638,000	$187,370,000	$83.35	206
2020 Q1	13,157,554	$178,738,588	+$88,861,816	$15,232,000	$15,526,000	$13.58	107
2019 Q4	6,654,109	$26,481,422	-$2,172,783	$5,070,000	$8,635,000	$3.98	65
2019 Q3	7,027,240	$35,282,234	+$1,163,958	$4,571,000	$10,361,000	$5.02	69
2019 Q2	6,731,130	$39,449,216	+$30,447,257	$4,260,000	$15,225,000	$5.86	70
2019 Q1	4,357,294	$2,534,000	+$2,400,000			$0.55	4
2016 Q4	0	$0	-$2,080			$6.72	0
2016 Q3	1,000	$2,080				$2.08	1
2016 Q2	1,000	$7,270	+$7,270			$7.27	1